Savara
SVRA
#6249
Rank
โ‚ฌ0.85 B
Marketcap
3,88ย โ‚ฌ
Share price
-18.23%
Change (1 day)
-9.10%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -โ‚ฌ0.13 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ0.11 Billion a decrease over its 2024 earnings that were of -โ‚ฌ87.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.13 Billion10.85%
2025 -โ‚ฌ0.11 Billion23.94%
2024 -โ‚ฌ87.41 Million75.29%
2023 -โ‚ฌ49.87 Million43.38%
2022 -โ‚ฌ34.78 Million-11.31%
2021 -โ‚ฌ39.22 Million-13.3%
2020 -โ‚ฌ45.23 Million-36.53%
2019 -โ‚ฌ71.27 Million13.76%
2018 -โ‚ฌ62.65 Million105.54%
2017 -โ‚ฌ30.48 Million34.11%
2016 -โ‚ฌ22.73 Million-37.43%
2015 -โ‚ฌ36.32 Million38.81%
2014 -โ‚ฌ26.17 Million33.62%
2013 -โ‚ฌ19.59 Million38.49%
2012 -โ‚ฌ14.14 Million24.59%
2011 -โ‚ฌ11.35 Million-36.5%
2010 -โ‚ฌ17.88 Million-3.14%
2009 -โ‚ฌ18.46 Million-23.28%
2008 -โ‚ฌ24.05 Million8.52%
2007 -โ‚ฌ22.17 Million-34.14%
2006 -โ‚ฌ33.66 Million184.43%
2005 -โ‚ฌ11.84 Million90.75%
2004 -โ‚ฌ6.21 Million190.35%
2003 -โ‚ฌ2.14 Million11.64%
2002 -โ‚ฌ1.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.15 Billion 14.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ16.56 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA